Table 2.
Association of statin treatment and clinical outcomes.
| Outcomes | Non-statin | Statin | p-value |
|---|---|---|---|
| In-hospital mortality [n (%)] | 925 (17.8) | 639 (12.3) | <0.001 |
| Mortality at day7 [n (%)] | 372 (7.2) | 184 (3.5) | <0.001 |
| Mortality at day30 [n (%)] | 793 (15.3) | 531 (10.2) | <0.001 |
| Mortality at day90 [n (%)] | 869 (16.8) | 586 (11.3) | <0.001 |
| Mechanical ventilation [n (%)] | 3,598 (69.4) | 3,550 (68.5) | 0.319 |
| Liver disease [n (%)] | 83 (1.6) | 53 (1.0) | 0.012 |
| Renal disease [n (%)] | 211 (4.1) | 357 (6.9) | <0.001 |
| Creatinine [mg/dL, M (SD)] | 1.4 (1.4) | 1.6 (1.8) | <0.001 |
| Duration of ICU stay [hours, M (SD)] | 152.2 (173.0) | 153.1 (199.11) | 0.823 |
| Duration of Hospital stay [days, M (SD)] | 15.1 (14.6) | 14.8 (14.9) | 0.354 |
Continuous variables are depicted as medians with interquartile ranges (IQRs) for data that do not follow a normal distribution. Categorical variables are represented through counts and corresponding percentages (%).